Treatment With Lenalidomide Modulates T-Cell Immunophenotype and Cytokine Production in Patients With Chronic Lymphocytic Leukemia

Cancer - United States
doi 10.1002/cncr.25983
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Management of Patients With Chronic Lymphocytic Leukemia Treated With Lenalidomide

Clinical Journal of Oncology Nursing
Oncology
2010English

Consolidation Treatment With Lenalidomide Following Front-Line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

HLA Ligandome Analysis of Primary Chronic Lymphocytic Leukemia (CLL) Cells Under Lenalidomide Treatment Confirms the Suitability of Lenalidomide for Combination With T-Cell-Based Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2018English

Cytokine Contents in Chronic Lymphocytic Leukemia: Association With ZAP70 Expression

Turkish Journal of Haematology
Hematology
2016English

Immune Dysfunction in Chronic Lymphocytic Leukemia T Cells and Lenalidomide as an Immunomodulatory Drug

Haematologica
Hematology
2009English

Peptide Vaccination Elicits Leukemia-Associated Antigen-Specific Cytotoxic CD8+ T-Cell Responses in Patients With Chronic Lymphocytic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Experience With Ibrutinib in Patients With Refractory and Recurrent B-Cell Chronic Lymphocytic Leukemia

Medical Council
2017English

Phenotypic Complexity of T Regulatory Subsets in Patients With B-Chronic Lymphocytic Leukemia

Modern Pathology
Forensic MedicinePathology
2011English

Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy